Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.08
Delayed Data
As of May 22
 0.00 / 0.00%
Today’s Change
0.93
Today|||52-Week Range
1.47
-6.09%
Year-to-Date
Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab
May 22 / Zacks.com - Paid Partner Content
Incyte (INCY) Announces Positive Data on Enzyme Inhibitor
May 18 / Zacks.com - Paid Partner Content
Merck's HIV Drug Gets Positive CHMP Opinion for Higher Dose
May 22 / Zacks.com - Paid Partner Content
Concert Pharma Falls After Clinical Hold on Hair Loss Drug
May 18 / Zacks.com - Paid Partner Content
Amgen Evenity Approval Derailed on Cardiovascular Side Effect
May 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021
May 18 / Zacks.com - Paid Partner Content
Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug
May 22 / Zacks.com - Paid Partner Content
Vertex Ups Kalydeco Sales View as FDA Okays Label Expansion
May 18 / Zacks.com - Paid Partner Content
Valeant (VRX) Decides to Extend Stay on Xifaxan's ANDA
May 19 / Zacks.com - Paid Partner Content
Alexion's (ALXN) Strensiq Results Positive in Long-Term Study
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.08
Today’s openn.a.
Day’s range-- - --
Volume300
Average volume (3 months)590,340
Market cap$109.9M
Dividend yield--
Data as of 05/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-277.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio3.3
Price/Sales0.97
Price/Book6.00

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...0.000.00%
VTLVital Therapies Inc0.000.00%
CPIXCumberland Pharmaceu...0.000.00%
GEMPGemphire Therapeutic...0.000.00%
Data as of 05/22/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts